CD44 and acute myeloid leukemia: Lapidot and colleagues showed that crosstalk exists between the CXCR4–SDF-1 axis and CD44 in normal hematopoietic cells and also that the use of specific antibodies disrupting those interactions blocked AML cell homing [21].